Hepatotoxicity and nephrotoxicity of 3-bromopyruvate in mice

Acta Cir Bras. 2016 Nov;31(11):724-729. doi: 10.1590/S0102-865020160110000004.

Abstract

Purpose:: To investigate the hepatotoxicity and nephrotoxicity of 3-Bromopyruvate (3BP) in mice.

Methods:: Fifteen nude mice were grafted subcutaneously in the left flank with MDA-MB-231 cells, then all mice were divided into control group (PBS), 3BP group (8 mg/kg), positive group (DNR: 0.8 mg/kg) when tumor volume reached approximately 100 mm3. 28 days later, tumors, livers and kidneys were stored in 4 % formalin solution and stained with hematoxylin and eosin staining. The Kunming mice experiment included control group (PBS), 3BP group (4mg/kg; 8mg/kg; 16mg/kg), positive group (DNR: 0.8 mg/kg). 24 hours later, the blood were used for the determination of hepatic damage serum biomarkers. Livers were stored in 4 % formalin solution for the later detection.

Results:: 3BP at the dose of 8mg/kg had a good effect on inhibiting tumor growth in nude mice and did not damage liver and kidney tissues. Kunming mice experiment showed 3BP at the dose of 16mg/kg did damage to liver tissues.

Conclusion:: 3-Bromopyruvate at the dose of suppressing tumor growth did not exhibit hepatotoxicity and nephrotoxicity in nude mice, and the effect on liver was confirmed in Kunming mice.

MeSH terms

  • Acute Kidney Injury / chemically induced
  • Acute Kidney Injury / pathology*
  • Animals
  • Chemical and Drug Induced Liver Injury / pathology*
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / toxicity*
  • Female
  • Kidney / drug effects*
  • Liver / drug effects*
  • Liver Neoplasms, Experimental / drug therapy
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Pyruvates / toxicity*

Substances

  • Enzyme Inhibitors
  • Pyruvates
  • bromopyruvate